IonOpticks

NEW RELEASE: IonOpticks, the world’s leading manufacturer of high-performance chromatography solutions for LC-MS-based proteomics, today announce the official release of Aurora Series® 5: the most significant robustness upgrade in the platform’s history. Aurora Series® 5 combines NEW CoreJet™ integrated emitter technology and a redesigned nanoZero® union with proven Aurora Series performance, delivering a step-change in robustness and lower cost per sample without compromising the depth and sensitivity researchers depend on. In extended testing on a Thermo Scientific Vanquish Neo UHPLC coupled to an Orbitrap Astral Zoom mass spectrometer, Series 5 sustained over 10,000 unique protein identifications across more than 1,000 injections on an 8-minute, 120-samples-per-day method, with no climb in backpressure beyond 1,400 runs. The result: nanoflow-level depth and sensitivity that laboratories can now run as a routine, high-throughput workflow rather than reserve for landmark experiments. Read the full release.

IonOpticks is pleased to announce the appointment of Rafael Pasquet as Chief Financial Officer, further strengthening the executive leadership team and bringing focus to strong governance, financial discipline, operational expansion and long-term commercial performance. Rafael joins IonOpticks with more than 17 years of international finance and executive leadership experience across Europe, Asia and Australia, bringing extensive expertise in financial management, governance, enterprise transformation, commercial strategy and organisational leadership. Continue reading.

IonOpticks is pleased to announce the addition of two new members to its Commercial team who will support our customers across the Asia-Pacific, India and MEA regions. Ying Ying Chan, Ph.D has been appointed as Sales Director APACI & MEA and Zhaoguan WU appointed as Field Applications Specialist, APACI & MEA. As IonOpticks continues to expand its global presence, strengthening regional expertise remains central to how the company supports its customers. With greater commercial leadership and technical capability across APACI and MEA, IonOpticks is well positioned to build closer relationships with researchers, increase opportunities for collaboration, and support the adoption of its chromatography solutions across a growing range of proteomics applications. Continue reading.

The cassette column format made plug-and-play nano LC-MS widely accessible. But some widely adopted designs never removed the emitter junction - they just hid it inside the housing. The union was still there, as was the dead volume. So was the band broadening you'd learn to accept as "normal." Aurora Series® keeps the format you're used to, but pulls the emitter from the same fused silica as the column itself. No junction, no union, nothing to vary. The result: 10–30% more peptide IDs, same sample, same instrument, same gradient. Your instrument has gotten faster. Your cohorts have gotten bigger. Has your column kept up? Read the full breakdown:

IonOpticks today announces a new collaboration with Aptila Biotech, the Berlin-based developer of DIA-NN, one of the most widely used software platforms for proteomics data analysis. Through this partnership, Aptila will support IonOpticks in deploying DIA-NN Enterprise across its chromatography systems and mass spectrometry method development, while IonOpticks will supply Aptila with state-of-the-art mass spectrometry data to help further optimise DIA-NN. By bringing together high-performance chromatography and leading data analysis, both companies aim to help researchers get more from every LC-MS run. Read the full release.

Registration Open. We invite you to join us for the next in our IonOpticks Insights webinar series to be presented by Amanda L. Smythers, PhD and hosted by IonOpticks' Zac Anderson.